BioSyent (CVE:RX) Stock Price Crosses Below 50 Day Moving Average – Time to Sell?

BioSyent Inc. (CVE:RX) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$11.26 and traded as low as C$11.03. BioSyent shares last traded at C$11.05, with a volume of 2,810 shares trading hands.

BioSyent Price Performance

The company has a debt-to-equity ratio of 3.19, a current ratio of 6.13 and a quick ratio of 6.91. The stock has a market capitalization of C$128.07 million, a price-to-earnings ratio of 18.42 and a beta of 0.93. The stock’s 50 day simple moving average is C$11.26 and its 200-day simple moving average is C$10.97.

Insider Activity at BioSyent

In related news, Senior Officer Robert Joseph March sold 4,775 shares of BioSyent stock in a transaction on Thursday, December 12th. The shares were sold at an average price of C$11.65, for a total value of C$55,628.75. Also, insider FAX Capital Corp. sold 230,800 shares of the company’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of C$11.12, for a total transaction of C$2,566,496.00. In the last 90 days, insiders sold 349,144 shares of company stock valued at $3,903,370. Insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.